103 related articles for article (PubMed ID: 27278606)
1. The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17β-estradiol.
Gómez-Gómez Y; Organista-Nava J; Ocadiz-Delgado R; García-Villa E; Leyva-Vazquez MA; Illades-Aguiar B; Lambert PF; García-Carrancá A; Gariglio P
Int J Oncol; 2016 Aug; 49(2):549-58. PubMed ID: 27278606
[TBL] [Abstract][Full Text] [Related]
2. Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein.
Ocadiz-Delgado R; Cruz-Colin JL; Alvarez-Rios E; Torres-Carrillo A; Hernandez-Mendoza K; Conde-Pérezprina JC; Dominguez-Gomez GI; Garcia-Villa E; Lambert PF; Gariglio P
J Physiol Biochem; 2021 Nov; 77(4):547-555. PubMed ID: 33937961
[TBL] [Abstract][Full Text] [Related]
3. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
6. Regulator role of HPV E7 protein on miR-21 expression in cervical carcinoma cells and its functional implication.
Kong Q; Wang W; Li P
Int J Clin Exp Pathol; 2015; 8(12):15808-13. PubMed ID: 26884851
[TBL] [Abstract][Full Text] [Related]
7. The HPV16 E7 oncoprotein increases the expression of Oct3/4 and stemness-related genes and augments cell self-renewal.
Organista-Nava J; Gómez-Gómez Y; Ocadiz-Delgado R; García-Villa E; Bonilla-Delgado J; Lagunas-Martínez A; Tapia JS; Lambert PF; García-Carrancá A; Gariglio P
Virology; 2016 Dec; 499():230-242. PubMed ID: 27693927
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice.
Gutiérrez J; García-Villa E; Ocadiz-Delgado R; Cortés-Malagón EM; Vázquez J; Roman-Rosales A; Alvarez-Rios E; Celik H; Romano MC; Üren A; Lambert PF; Gariglio P
Mol Cell Biochem; 2015 Oct; 408(1-2):261-72. PubMed ID: 26173416
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.
Cortés-Malagón EM; Bonilla-Delgado J; Díaz-Chávez J; Hidalgo-Miranda A; Romero-Cordoba S; Uren A; Celik H; McCormick M; Munguía-Moreno JA; Ibarra-Sierra E; Escobar-Herrera J; Lambert PF; Mendoza-Villanueva D; Bermudez-Cruz RM; Gariglio P
Virology; 2013 Dec; 447(1-2):155-65. PubMed ID: 24210110
[TBL] [Abstract][Full Text] [Related]
10. Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells.
Zhang S; Liu F; Mao X; Huang J; Yang J; Yin X; Wu L; Zheng L; Wang Q
Int J Oncol; 2015 Nov; 47(5):1759-66. PubMed ID: 26397063
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P
Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435
[TBL] [Abstract][Full Text] [Related]
12. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression between skin and cervix induced by the E7 oncoprotein in a transgenic mouse model.
Ibarra Sierra E; Díaz Chávez J; Cortés-Malagón EM; Uribe-Figueroa L; Hidalgo-Miranda A; Lambert PF; Gariglio P
Virology; 2012 Nov; 433(2):337-45. PubMed ID: 22980503
[TBL] [Abstract][Full Text] [Related]
14. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
15. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.
Chen Y; Sun L; Li L
J Obstet Gynaecol; 2024 Dec; 44(1):2311658. PubMed ID: 38348790
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.
Shishodia G; Verma G; Srivastava Y; Mehrotra R; Das BC; Bharti AC
BMC Cancer; 2014 Dec; 14():996. PubMed ID: 25539644
[TBL] [Abstract][Full Text] [Related]
18. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
19. Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.
Munguía-Moreno JA; Díaz-Chavéz J; García-Villa E; Albino-Sanchez ME; Mendoza-Villanueva D; Ocadiz-Delgado R; Bonilla-Delgado J; Marín-Flores A; Cortés-Malagón EM; Alvarez-Rios E; Hidalgo-Miranda A; Üren A; Çelik H; Lambert PF; Gariglio P
Int J Oncol; 2018 Aug; 53(2):579-591. PubMed ID: 29901186
[TBL] [Abstract][Full Text] [Related]
20. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
